WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 202
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 252

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 25'369  25'244  25'116  24'986  24'854  22'929  20'293  17'472 
Births 351  350  350  349  350  412  421  361 
Surviving infants 346  345  344  343  343  393  406  350 
Pop. less than 5 years 1'726  1'710  1'706  1'699  1'697  1'988  1'950  1'686 
Pop. less than 15 years 5'294  5'328  5'378  5'425  5'472  5'947  5'505  6'402 
Female 15-49 years 6'691  6'711  6'712  6'694  6'662  6'115  5'750  4'620 

Number of reported cases

(Click for retrospective incidence data for Democratic People's Republic of Korea (the))
Diphtheria
ChartChart
  18 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
 
Mumps
ChartChart
  11 
Pertussis
ChartChart
  304  58 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  537 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Democratic People's Republic of Korea (the))
Vaccine year result method % card seen                                                
BCG 2007  97  EPI   100  97  97  98  98  98  82  99  50 
DTP1 2007  94  EPI   100  97  97  94  94  97  82 
DTP3 2007  92  EPI   100  96  96  93  93  96  80  98  50 
DTP4         
IPV1          25  99 
HepB_BD          98  97  99  99  99 
HepB3 2007  92  EPI   100  96  96  93  96  30 
Hib3          96  96  93  96 
JapEnc         
MCV1          99  98  99  99  99  92  98  29 
MCV2          98  97  99  99  99 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2007  99  EPI   100  99  99  99  99  99  98  99  50 
Rota1         
RotaC         
RCV1         
TT2plus 1999  74  MICS   99  99  98  97  99  99  84  98 
PAB         
VAD1          99  98  99  99*  99* 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Democratic People's Republic of Korea (the))
BCG
ChartChart
  97  97  98  98  98  78  99  50 
DTP1
ChartChart
  97  97  94  94  97  61  98  74 
DTP3
ChartChart
  96  96  93  93  96  56  98  50 
HepB3
ChartChart
  96  96  93  93  96 
HepB_BD
ChartChart
  98  97  99  99  99 
Hib3
ChartChart
  96  96  93  93  32 
IPV1
  25  99 
MCV1
ChartChart
  99  98  99  99  99  78  98  29 
MCV2
ChartChart
  98  97  99  99  99 
PCV3
 
Pol3
ChartChart
  99  99  99  99  99  93  99  50 
RCV1
 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 210  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
IPV 14 weeks; Yes
Measles 9, 15 months; Yes
OPV 6, 10, 14 weeks; Yes
Td pregnant women at 3, 4 months; Yes
VitaminA 6-59 months (2 doses); Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 210  210  210  209  208     

System performance

Total Nº districts in country number 210  210  210  209  208  208  208 
Nº districts with DTP3 coverage >=80% number 210  210  210  209  208  208  208 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 210  210  210  209  208  208  208 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% NA    48  48  50    27 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.